BD Biosciences collaborates with CSIR-IGIB to set up its first CoE for single cell Multiomics

The new CoE is designed to advance single-cell multiomics research by integrating BD’s Rhapsody™ Single Cell Analysis Solutions with IGIB’s capabilities in high-throughput next-generation sequencing (NGS) and bioinformatics

0
82
New Delhi: BD Life Sciences–Biosciences, a segment of BD (Becton, Dickinson and Company), in collaboration with the Institute of Genomics and Integrative Biology (IGIB), have announced the inauguration of its first Centre of Excellence (CoE) for Single-Cell Multiomics in India.
The new CoE is designed to advance single-cell multiomics research by integrating BD’s Rhapsody™ Single Cell Analysis Solutions with IGIB’s capabilities in high-throughput next-generation sequencing (NGS) and bioinformatics.
Commenting on the launch, Atul Grover, Managing Director, BD India/South Asia, said that the Single-Cell Multiomics Centre of Excellence reflects BD’s commitment to equipping scientists with advanced tools that enable innovation in health research. By offering deeper insights into cellular function, the initiative aims to accelerate discoveries in areas such as immunity and cancer. He added that the centre will function as a hub for training, application support, and collaboration, helping researchers translate complex scientific challenges into real-world solutions in line with BD’s purpose of advancing the world of health.
Dr. Souvik Maiti, Director of CSIR–Institute of Genomics and Integrative Biology (IGIB), noted that IGIB is a premier biology institute under the Council of Scientific and Industrial Research (CSIR), engaged in research of national importance across genomics, molecular medicine, bioinformatics, and proteomics. He said the partnership with BD will create a collaborative platform to strengthen India’s capabilities in single-cell multiomics and foster innovation in precision medicine.
Dr. Rajesh Pandey, Principal Scientist at CSIR–IGIB, described the collaboration as a transformative step toward building a robust ecosystem for single-cell multiomics in India. He said the initiative will not only accelerate cutting-edge scientific discoveries but also establish a knowledge-sharing and capacity-building platform that empowers researchers and clinicians to drive innovation in precision healthcare.
In addition to the newly launched centre, BD Biosciences has established several other Centres of Excellence in India, including the BD–NCBS CoE in Advanced Flow Cytometry in Bengaluru, the BD–CMC Vellore CoE in Clinical Flow Cytometry, the BD–JH FACS Academy, and the BD–Sehgal Path Lab CoE in Mumbai.